Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conditional-siRNAS and uses thereof in treating acute myeloid leukemia

Conditional-siRNAS and uses thereof in treating acute myeloid leukemia

US Patent 11643659 · Granted May 9, 2023

Estimated economic value: $6,754,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IL1RAP antibodies2025
Modification of small RNAs for therapeutic uses2025
Conditional-siRNAS and uses thereof in treating cardiac hypertrophy2025
Conditional-siRNAS and uses thereof in treating cardiac hypertrophy2025
Conditional-siRNAS and uses thereof in treating cardiac hypertrophy2025
Conditional-siRNAS and uses thereof in treating cardiac hypertrophy2025
Screening methods and related catalysts, materials, compositions, methods and sy2025
Compounds and compositions including phosphorothioated oligodeoxynucleotide, and2025
Compounds and compositions including phosphorothioated oligodeoxynucleotide, and2025
CCR7 aptamers and uses thereof2025
Bi specific aptamer2024
Electron bias control signals for electron enhanced material processing2024